Roush John A 4

What Happened

John A. Roush, a director of Lemaitre Vascular, acquired shares upon settlement of a Performance Share Unit (PSU) award that vested on February 26, 2026. The filing reports 476 shares received as the PSU settlement (code A) and an additional 1 share related to released dividend equivalent rights (reported as conversions/exercises, code M). One derivative share was also reported disposed (code M) in connection with the same settlement. All reported share acquisitions were recorded at $0.00 (award settlement).

Key Details

• Transaction date: February 26, 2026; Form 4 filed March 2, 2026 (timely within SEC two-business-day rule).
• Shares acquired: 476 shares (PSU settlement) + 1 share (dividend equivalent conversion) = 477 shares acquired; 1 derivative share reported disposed.
• Price: $0.00 per share (award/settlement), so no cash purchase amount reported.
• Footnotes:
  • F1 — 476 shares settled from a PSU granted Dec 6, 2024; 1/3 vested upon performance determination on 2/26/2026, remainder vests over next two anniversaries.
  • F2/F3 — 1 share represents release of dividend equivalent rights tied to the PSU (each dividend equivalent equals one share).
• Shares owned after the transaction are not specified in the provided excerpt.

Context

This activity reflects compensation vesting (award settlement) rather than an open-market purchase or sale. Such vested awards are common executive/director compensation and do not by themselves indicate insider buying or selling sentiment. The derivative entries reflect conversion/release of rights tied to the PSU (including dividend equivalents).